You are using an outdated browser. For a faster, safer browsing experience, upgrade for free today.


Pharmacogenetics Platform

Enabling Safe & Efficient Drug Therapy Based On The Results Of Genetic Testing

Get To Know Us


Personalized Medicine Solutions

Precision Treatment Tuned with Advanced Technologies

Explore Services


Innovative AI Algorithms

Advanced Solutions for Pharmacogenetic Data Analysis

More About Technology


Meet Our Team of Experts

Professionalism and Innovation in Every Aspect of Our Work

About Us

About us

Welcome to PGxAI, a company at the forefront of scientific research and innovation in the field of pharmacogenetics. Our mission is to harness genetic data to craft personalized medical solutions, ensuring the most effective and safest treatments for patients.

Our team is a unique blend of scientists, engineers, medical professionals, and entrepreneurs, all united by a single goal: to transform modern healthcare through cutting-edge technologies. Each member of our team is an expert in their respective field, and together, we are dedicated to creating solutions that can change lives.

Advantages of PGxAI

AI-Powered Technology:

PGxAI harnesses cutting-edge AI capabilities, enabling instantaneous analysis of pharmacogenetic data for the first time. This ensures rapid and accurate results tailored to individual needs.

Extensive Drug Database:

Our platform boasts the largest drug database across all clinical specialties, encompassing over 730 medications. This vast range ensures comprehensive analysis catering to diverse patient requirements.

Cost-Effective Analysis:

At a rate of approximately $0.055 per drug analysis, PGxAI offers unparalleled value, making our services significantly more affordable compared to competitors.

Holistic Drug Interaction Analysis:

Beyond individual drug assessments, PGxAI provides an in-depth drug interaction analysis, identifying potential risks associated with combined medication intake (drug-drug interaction checker). Additionally, our platform can pinpoint health risks such as thrombosis and atherosclerosis, positioning PGxAI not just as a drug analysis tool, but a vital health assessment instrument.


Our search in the realm of personalized medicine is a harmonious blend of clinical pharmacology, genetics and cutting-edge technology. Here's a glimpse into our process:

EnablingSafe & Efficient Drug Therapy
Based On The Results Of Genetic Testing

Join us in our mission to redefine healthcare, making it more personalized, effective, and forward-thinking.

Our Team

Allan Gobbs

Executive Chairman & Co-Founder
Venture Investor, 5 NASDAQ IPOs + 4 M&As

Michael Zastrozhin

CEO & Co-Founder
MD PhD, Bioengineering and Therapeutical Sciences at UCSF

Jason Akram

VP of Business
Neuroscience and Finance at Stanford

Alex Raud

VP of Development
Architect, Product Manager at Intel

Rami Sarkis

International Partner

Emily Chen

Scientific Advisor
Senior Director at Thermo Fisher Precision Medicine Science Center

Lisa Brown

Scientific Advisor
Senior Medical Science Liaison at Tempus Labs

Dave Vigerust

Scientific Advisor
Chief Scientific Officer at Spectrum Solutions

Terry Robins

Business Advisor
Senior Director Clinical Affairs at Abbott

Joydeep Bhattacharyya

Business Advisor
Ex-Director Innovation, Strategy & Product at GE Healthcare

Latest News

Our Partners